Goldman Sachs Lowers Rating on St. Jude Medical (STJ)

By
A A A
Share |

Goldman Sachs has downgraded medical company, St. Jude Medical, Inc.( STJ ) Thursday to "Neutral."

The firm lowered its rating of the St. Paul, MN company from a "Buy" to "Neutral" and have lowered their price target from $48 to $42. This price suggests a 4.7% increase from the stock's current price of $40, and a 18.3% increase from the stock's YTD price of $34.30.

An analyst from the firm noted, "the company's core business is facing greater headwinds than we had contemplated; while new growth drivers are gaining traction at a slower rate. We no longer see the potential for a material improvement in growth or a positive re-rating in the P/E multiple."

St. Jude Medical shares were down 81 cents, or 1.98% Thursday morning.

The Bottom Line
Shares of St.Jude Medical ( STJ ) have a 2.25% dividend yield, based on last night's closing stock price of $40.85. The stock has technical support in the $36-$38 price area. If the shares can firm up, we see overhead resistance around the $44 price level.

St. Jude Medical, Inc.( STJ )is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.2 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: STJ

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

106,053,772
  • $3.94 ▲ 3.14%
69,746,652
  • $7.29 ▼ 6.06%
55,667,241
  • $30.43 ▼ 6.46%
51,815,872
    $22.81 unch
49,010,228
  • $15.285 ▼ 1.89%
45,179,536
  • $95.72 ▼ 2.48%
39,750,989
  • $45.2231 ▼ 2.33%
37,715,524
  • $94.965 ▼ 2.08%
As of 7/31/2014, 03:20 PM